[HTML][HTML] Activating mutations of the stimulatory G protein in the McCune–Albright syndrome
…, PV Gejman, MJ Merino, E Friedman… - … England Journal of …, 1991 - Mass Medical Soc
Background. The McCune-Albright syndrome is a sporadic disease characterized by
polyostotic fibrous dysplasia, café au lait spots, sexual precocity, and hyperfunction of multiple …
polyostotic fibrous dysplasia, café au lait spots, sexual precocity, and hyperfunction of multiple …
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention
…, JJ Valle‐Goffin, ER Friedman… - CA: a cancer journal …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE Recent decades have seen an unprecedented rise
in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more …
in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more …
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation
…, P Moller, B Rosen, J Murphy, P Ghadirian, E Friedman… - Jama, 2006 - jamanetwork.com
ContextWomen with BRCA1 or BRCA2 mutation are often advised to undergo preventive
oophorectomy. The effectiveness of this intervention has not been prospectively evaluated in a …
oophorectomy. The effectiveness of this intervention has not been prospectively evaluated in a …
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
…, S Paluch-Shimon, R Berger, J Zidan, E Friedman… - Jama, 2015 - jamanetwork.com
Importance Limited information about the relationship between specific mutations
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …
[PDF][PDF] Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
…, WD Foulkes, R Gershoni-Baruch, E Friedman… - Journal of clinical …, 2005 - seom.org
Purpose The purpose of this study was to estimate the extent of protection offered against
breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to …
breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to …
[HTML][HTML] Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a BRCA1 or BRCA2 Mutation
…, MA Tucker, SM Ebbers, E Friedman… - … England Journal of …, 2001 - Mass Medical Soc
Background Multiparity and the use of oral contraceptives reduce the risk of ovarian cancer,
but their effects on this risk in women with a BRCA1 or BRCA2 mutation are unclear. …
but their effects on this risk in women with a BRCA1 or BRCA2 mutation are unclear. …
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
…, WD Foulkes, J Klijn, E Friedman… - … journal of cancer, 2008 - Wiley Online Library
Several options for cancer prevention are available for women with a BRCA1 or BRCA2
mutation, including prophylactic surgery, chemoprevention and screening. The authors report …
mutation, including prophylactic surgery, chemoprevention and screening. The authors report …
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
…, K Offit, C Isaacs, B Weber, E Friedman… - Journal of the …, 2002 - academic.oup.com
Background: Oral contraceptive use has been associated with an increase in the risk of breast
cancer in young women. We examined whether this association is seen in women at high …
cancer in young women. We examined whether this association is seen in women at high …
New evidence for neurotransmitter influences on brain development
P Levitt, JA Harvey, E Friedman, K Simansky… - Trends in …, 1997 - cell.com
The early appearance of monoamine systems in the developing mammalian CNS suggests
that they play a role in neural development. We review data from two model systems that …
that they play a role in neural development. We review data from two model systems that …
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general …
…, JF Boggess, J Basil, SV Blank, E Friedman… - Nature …, 2010 - nature.com
Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …